D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$516M |
| 2 |
Estee Lauder
EL
|
+$487M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
Nike
NKE
|
+$252M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$584M |
| 2 |
Tesla
TSLA
|
+$483M |
| 3 |
NVIDIA
NVDA
|
+$444M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
T-Mobile US
TMUS
|
+$296M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.67% |
| 2 | Consumer Discretionary | 9.3% |
| 3 | Healthcare | 7.82% |
| 4 | Financials | 5.66% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
CALL
Robinhood
HOOD
$85.9B
| $838K | ﹤0.01% |
85,400
-164,100
| -66% | -$1.82M |
|
|
OAKU
3027
DELISTED
Oak Woods Acquisition Corp
OAKU
| $836K | ﹤0.01% |
80,000
| – | – |
|
3028
Karyopharm Therapeutics
KPTI
$161M
| $835K | ﹤0.01% |
41,524
+1,673
| +4% | +$37.5K |
|
|
SEM
3029
DELISTED
Select Medical
SEM
| $834K | ﹤0.01% |
+61,270
| New | +$946K |
|
|
VRTV
3030
DELISTED
VERITIV CORPORATION
VRTV
| $834K | ﹤0.01% |
4,935
-22,202
| -82% | -$3.44M |
|
|
SPR
3031
CALL
DELISTED
Spirit AeroSystems
SPR
| $833K | ﹤0.01% |
51,600
| – | – |
|
3032
Adeia
ADEA
$2.88B
| $830K | ﹤0.01% |
77,693
-70,242
| -47% | -$746K |
|
3033
Xperi
XPER
$367M
| $829K | ﹤0.01% |
84,038
+27,497
| +49% | +$325K |
|
|
CVGW
3034
DELISTED
Calavo Growers
CVGW
| $828K | ﹤0.01% |
+32,837
| New | +$1.07M |
|
|
RYZ
3035
Ryerson Holding Corp
RYZ
$1.59B
| $826K | ﹤0.01% |
28,385
-150,928
| -84% | -$5.12M |
|
3036
Regal Rexnord
RRX
$14B
| $823K | ﹤0.01% |
5,763
+1,963
| +52% | +$302K |
|
3037
SiriusPoint
SPNT
$3.01B
| $823K | ﹤0.01% |
80,900
| – | – |
|
3038
CALL
BRC Group Holdings
RILY
$273M
| $820K | ﹤0.01% |
20,000
| – | – |
|
3039
CALL
Jones Lang LaSalle
JLL
$15.5B
| $819K | ﹤0.01% |
+5,800
| New | +$947K |
|
3040
Otter Tail
OTTR
$3.87B
| $818K | ﹤0.01% |
10,776
+4,976
| +86% | +$409K |
|
|
ONIT
3041
Onity Group
ONIT
$336M
| $817K | ﹤0.01% |
31,567
+4,023
| +15% | +$121K |
|
3042
CALL
Coherent
COHR
$53.1B
| $816K | ﹤0.01% |
25,000
| – | – |
|
3043
PUT
Novavax
NVAX
$1.23B
| $815K | ﹤0.01% |
112,500
+50,000
| +80% | +$400K |
|
3044
Krispy Kreme
DNUT
$562M
| $813K | ﹤0.01% |
65,161
-124,803
| -66% | -$1.74M |
|
3045
CALL
Elastic
ESTC
$6.37B
| $812K | ﹤0.01% |
10,000
| – | – |
|
3046
TPG
TPG
$6.89B
| $812K | ﹤0.01% |
26,943
-185,285
| -87% | -$5.4M |
|
3047
Clarus
CLAR
$126M
| $810K | ﹤0.01% |
107,133
+5,885
| +6% | +$47.1K |
|
|
SIX
3048
DELISTED
Six Flags Entertainment Corp.
SIX
| $809K | ﹤0.01% |
34,406
-82,996
| -71% | -$1.96M |
|
3049
Stoke Therapeutics
STOK
$1.83B
| $808K | ﹤0.01% |
205,166
+88,701
| +76% | +$583K |
|
3050
C4 Therapeutics
CCCC
$397M
| $807K | ﹤0.01% |
434,110
-85,069
| -16% | -$259K |
|
Similar funds
D.E. Shaw & Co's Q3 2023 Portfolio in Review
As of Q3 2023, D.E. Shaw & Co held 4,689 positions worth $95.8B, down 2.2% from $97.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $2.99B in Q3 2023, closing 473 positions and reducing 1,535 holdings. Its most notable exit was State Street Consumer Staples Select Sector SPDR ETF, an estimated $174M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in NiSource Inc. Series A Corporate Units worth $52.6M.
- D.E. Shaw & Co's largest Q3 2023 buy was NiSource Inc. Series A Corporate Units: 540,000 shares worth $52.6M.
- D.E. Shaw & Co added most to Amazon in Q3 2023, an estimated $516M increase.
- D.E. Shaw & Co's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $584M.
- D.E. Shaw & Co fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2023, selling an estimated $174M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $95.8B portfolio in Q3 2023.
- D.E. Shaw & Co opened 482 new positions and closed 473 in Q3 2023.
- D.E. Shaw & Co's portfolio value fell 2.2% quarter-over-quarter to $95.8B.
Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.